SPY—
QQQ—
DIA—
NVDA—
AAPL—
TSLA—
MSFT—
BTC-USD—
15-min delayed
Home Market News Price Targets Penny Stocks Crypto Economy Commodities Education
Stocks About Contact

Johnson & Johnson

JNJ XNYS
$254.82 +1.79 (+0.71%) ▲ 15-min delayed
Open
$254.15
High
$255.48
Low
$251.17
Volume
3.66M
Market Cap
$609.54B

About Johnson & Johnson

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 140.8K Website →

Key Financials

Period Revenue Net Income EPS
Q2 2027 $25.31B $5.53B $2.30
Q4 2026 $24.06B $5.24B $2.17
FY 2025 $94.19B $26.80B $11.13
Q3 2025 $23.99B $5.15B $2.14

Get JNJ Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Johnson & Johnson.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.